Insider trades
Carl L. Gordon, Director of ADARx Pharmaceuticals ADRX, has filed 37 purchases and 10 sales on the open market. Over the past 12 months that comes to a net purchase of $36.1M. The latest trade was on 09/28.
Carl L. Gordon
Director
- Company
- ADARx Pharmaceuticals ADRX
- First filing
- 23/02/09
- Trades
- 152 trades
- Buys / sales
- 37 / 10
- 12-month net buying
- $36.1M
- Last trade
- 09/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 09/28 | 09/30 | 950,000 sh3 trades | $17.00avg. | $16,150,000 | No record | |
| Open-market buy | 09/21 | 09/23 | 1,333,333 sh2 trades | $15.00avg. | $19,999,995 | +313.8% | |
| Open-market sale | 25/04/09 | 25/04/11 | 3,571,428 sh | $1.59 | $5,678,570.52 | −100.0% | |
| Open-market buy | 25/02/14–25/02/18 | 25/02/19 | 190,672 sh4 trades | $10.60avg. | $2,020,755.6 | +34.2% | |
| Open-market buy | 24/09/16 | 24/09/17 | 750,000 sh2 trades | $16.00avg. | $12,000,000 | No record | |
| Open-market sale | 24/08/13 | 24/08/15 | 250,000 sh2 trades | $44.01avg. | $11,002,500 | −67.7% | |
| Open-market sale10b5-1 plan | 24/07/15–24/07/16 | 24/07/17 | 56,164 sh6 trades | $10.00avg. | $561,640 | −6.9% | |
| Open-market sale | 24/05/15 | 24/05/20 | 24,344 sh | $0.38 | $9,250.72 | −0.2% | |
| Open-market buy | 24/01/30 | 24/01/31 | 444,444 sh2 trades | $18.00avg. | $7,999,992 | +41.6% | |
| Open-market buy | 24/01/25 | 24/01/26 | 3,125,000 sh3 trades | $2.40avg. | $7,500,000 | No record | |
| Open-market buy | 23/07/17 | 23/07/19 | 479,932 sh2 trades | $3.05avg. | $1,463,792.6 | +281.2% | |
| Open-market buy | 23/06/27 | 23/06/29 | 875,000 sh4 trades | $2.09avg. | $1,828,750 | No record | |
| Open-market buy | 23/05/04–23/05/05 | 23/05/08 | 1,460,932 sh5 trades | $2.80avg. | $4,086,234.61 | No record | |
| Open-market buy | 23/04/28–23/05/02 | 23/05/02 | 1,405,168 sh9 trades | $2.61avg. | $3,673,900.83 | No record | |
| Open-market buy | 23/02/27 | 23/03/17 | 348,000 sh | $0.25 | $87,000 | +12.4% |
